Immunoregulatory natural compounds in stress-induced depression: An alternative or an adjunct to conventional antidepressant therapy?

Abstract

The interplay of chronic stress, neuroinflammation and altered immune reactivity has been shown to be important for the pathophysiology of brain disorders such as schizophrenia, depressive disorders and post-traumatic stress disorder. This immuno-inflammatory theory has been extensively studied in the past three decades leading to the formation of the integrative discipline of psychoneuroimmunology. Targeting of the central nervous system by conventional pharmacotherapeutic methods is mainly through modulation of neuroendocrine systems such as the dopaminergic, GABA-ergic, adrenergic and serotoninergic systems. In recent years an increasing number of both experimental and clinical studies have shown that antidepressants can affect the immune system by reducing the production of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α. However, due to the serious adverse effects accompanying the chronic administration of psychoactive drugs there is a continuous need to produce novel therapeutics that are both potent and safe. The present review aims to summarize the current knowledge in the field of psychoneuroimmunology and to delineate the main interactions between stress, inflammation, immunity and the brain. Additionally, this paper explores the use of plant-derived molecules that display a strong anti-stress effect and simultaneously modulate the immune response as an alternative or adjuvant to classical antidepressant drugs.

Passiflora incarnata in Neuropsychiatric Disorders—A Systematic Review

“…In the past year, the academic interest in these disorders has been growing due to the COVID-19 pandemic and the related upsurge in anxiety and depression [36]. Pharmacotherapy is effective, but, at the same time, it carries the risk of side effects and dependence [37]. Hence, the search for herbal remedies for neuropsychiatric disorders continues to go on [38].…”

Memantine in neurological disorders – schizophrenia and depression

“…Depressive disorders may be triggered by chronic inflammation in brain associated with chronically increased levels of cytokines or other inflammatory mediators [69]. Such elevation induces a chain of endocrine reactions leading to neurotoxicity [70]. As neuroplasticity plays a significant role in the onset of depression, less neuroplasticity is associated with greater visibility of symptoms [71].…”

Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies—A Comprehensive Review

“…The metabolic phenotype of PTSD may be caused partially by glucocorticoid hypersensitivity, which may affect inflammation, insulin resistance, oxidative stress, and energy deficiency [79]. PTSD patients have suppressed HPA axis activity, which progressively leads to increased catecholamine levels, corticotropin-releasing factor (CRF), and reduced cortisol levels [45,47,80]. A report by Heim C et al, 2008, found that the childhood exposure to severe abuse leads to sustained stress responses through persistent CRF-receptor activity in the later life [81].…”